The DOI matches its Crossref record; 143 of the 143 references it cites were found in a registry or an index.
G-protein-coupled receptors and cancer
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Targeting HIF-1 for cancer therapy
Semenza, G. L. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1187 · Cited by 6,717
Involvement of chemokine receptors in breast cancer metastasis
Müller, A., Homey, B., Soto, H., Ge, N., Catron, D., Buchanan, M. E., McClanahan, T., Murphy, E., Yuan, W., Wagner, S. N., et al. (2001) · Nature · doi:10.1038/35065016 · Cited by 5,340
Cancer genes and the pathways they control
Vogelstein, B., & Kinzler, K. W. (2004) · Nature Medicine · doi:10.1038/nm1087 · Cited by 4,249
How Matrix Metalloproteinases Regulate Cell Behavior
Sternlicht, M. D., & Werb, Z. (2001) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.17.1.463 · Cited by 3,959
Dissemination and growth of cancer cells in metastatic sites
Chambers, A. F., Groom, A. C., & MacDonald, I. C. (2002) · Nature Reviews Cancer · doi:10.1038/nrc865 · Cited by 3,911
Pierce, K. L., Premont, R. T., & Lefkowitz, R. J. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm908 · Cited by 2,701
Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1
Ceradini, D. J., Kulkarni, A. R., Callaghan, M. J., Tepper, O. M., Bastidas, N., Kleinman, M. E., Capla, J. M., Galiano, R. D., Levine, J. P., & Gurtner, G. C. (2004) · Nature Medicine · doi:10.1038/nm1075 · Cited by 2,600
Cardiovascular Events Associated with Rofecoxib in a Colorectal Adenoma Chemoprevention Trial
Bresalier, R. S., Sandler, R. S., Quan, H., Bolognese, J. A., Oxenius, B., Horgan, K., Lines, C., Riddell, R., Morton, D., Lanas, A., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050493 · Cited by 2,519
Thrombin signalling and protease-activated receptors
Coughlin, S. R. (2000) · Nature · doi:10.1038/35025229 · Cited by 2,482
Cancer and the chemokine network
Balkwill, F. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1388 · Cited by 2,343
The development of androgen-independent prostate cancer.
Feldman, B. J., & Feldman, D. (2001) · Nature reviews. Cancer · doi:10.1038/35094009 · Cited by 2,326
A transmembrane intracellular estrogen receptor mediates rapid cell signaling
Revankar, C. M., Cimino, D. F., Sklar, L. A., Arterburn, J. B., & Prossnitz, E. R. (2005) · Science · doi:10.1126/science.1106943 · Cited by 2,302
WNT and β-catenin signalling: diseases and therapies
Moon, R. T., Kohn, A. D., Ferrari, G. V. D., & Kaykas, A. (2004) · Nature Reviews Genetics · doi:10.1038/nrg1427 · Cited by 1,763
Metastasis suppressor gene KiSS-1 encodes peptide ligand of a G-protein-coupled receptor
Ohtaki, T., Shintani, Y., Honda, S., Matsumoto, H., Hori, A., Kanehashi, K., Terao, Y., Kumano, S., Takatsu, Y., Masuda, Y., et al. (2001) · Nature · doi:10.1038/35079135 · Cited by 1,448
Landis, C. A., Masters, S. B., Spada, A., Pace, A. M., Bourne, H. R., & Vallar, L. (1989) · Nature · doi:10.1038/340692a0 · Cited by 1,441
Identity of an Estrogen Membrane Receptor Coupled to a G Protein in Human Breast Cancer Cells
Thomas, P., Pang, Y., Filardo, E. J., & Dong, J. (2005) · Endocrinology · doi:10.1210/en.2004-1064 · Cited by 1,407
Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential
Tsujii, M., Kawano, S., & DuBois, R. N. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.7.3336 · Cited by 1,398
Filardo, E. J. (2000) · Molecular Endocrinology · doi:10.1210/me.14.10.1649 · Cited by 1,383
Activating Smoothened mutations in sporadic basal-cell carcinoma
Xie, J., Murone, M., Luoh, S.-M., Ryan, A., Gu, Q., Zhang, C., Bonifas, J. M., Lam, C.-W., Hynes, M., Goddard, A., et al. (1998) · Nature · doi:10.1038/34201 · Cited by 1,334
Neves, S. R., Ram, P. T., & Iyengar, R. (2002) · Science · doi:10.1126/science.1071550 · Cited by 1,286
CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment
Burger, J. A., & Kipps, T. J. (2006) · Blood · doi:10.1182/blood-2005-08-3182 · Cited by 1,170
The emerging role of lysophosphatidic acid in cancer
Mills, G. B., & Moolenaar, W. H. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1143 · Cited by 1,094
PPARδ Is an APC-Regulated Target of Nonsteroidal Anti-Inflammatory Drugs
He, T.-C., Chan, T. A., Vogelstein, B., & Kinzler, K. W. (1999) · Cell · doi:10.1016/s0092-8674(00)81664-5 · Cited by 1,085
KiSS-1, a Novel Human Malignant Melanoma Metastasis-Suppressor Gene
Lee, J.-H., Miele, M. E., Hicks, D. J., Phillips, K. K., Trent, J. M., Weissman, B. E., & Welch, D. R. (1996) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/88.23.1731 · Cited by 1,072
Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2
Gupta, R. A., & DuBois, R. N. (2001) · Nature Reviews Cancer · doi:10.1038/35094017 · Cited by 1,066
G-protein-coupled receptors and signaling networks: emerging paradigms
Marinissen, M. J., & Gutkind, J. S. (2001) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01678-3 · Cited by 1,049
Self-citationTwo G Protein Oncogenes in Human Endocrine Tumors
Lyons, J., Landis, C. A., Harsh, G., Vallar, L., Grünewald, K., Feichtinger, H., Duh, Q.-Y., Clark, O. H., Kawasaki, E., Bourne, H. R., et al. (1990) · Science · doi:10.1126/science.2116665 · Cited by 1,037
Hiratsuka, S., Watanabe, A., Aburatani, H., & Maru, Y. (2006) · Nature Cell Biology · doi:10.1038/ncb1507 · Cited by 1,015
Sirolimus for Kaposi's Sarcoma in Renal-Transplant Recipients
Stallone, G., Schena, A., Infante, B., Di Paolo, S., Loverre, A., Maggio, G., Ranieri, E., Gesualdo, L., Schena, F. P., & Grandaliano, G. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042831 · Cited by 990
Wnt signaling in disease and in development
NUSSE, R. (2005) · Cell Research · doi:10.1038/sj.cr.7290260 · Cited by 973
Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas
Parma, J., Duprez, L., Sande, J. V., Cochaux, P., Gervy, C., Mockel, J., Dumont, J., & Vassart, G. (1993) · Nature · doi:10.1038/365649a0 · Cited by 918
Prostaglandin E 2 Promotes Colon Cancer Cell Growth Through a G s -Axin-ß-Catenin Signaling Axis
Castellone, M. D., Teramoto, H., Williams, B. O., Druey, K. M., & Gutkind, J. S. (2005) · Science · doi:10.1126/science.1116221 · Cited by 883
Self-citationPolarization of Chemoattractant Receptor Signaling During Neutrophil Chemotaxis
Servant, G., Weiner, O. D., Herzmark, P., Balla, T., Sedat, J. W., & Bourne, H. R. (2000) · Science · doi:10.1126/science.287.5455.1037 · Cited by 877
Chemokine receptor CXCR4 downregulated by von Hippel–Lindau tumour suppressor pVHL
Staller, P., Sulitkova, J., Lisztwan, J., Moch, H., Oakeley, E. J., & Krek, W. (2003) · Nature · doi:10.1038/nature01874 · Cited by 870
The Hedgehog Response Network: Sensors, Switches, and Routers
Lum, L., & Beachy, P. A. (2004) · Science · doi:10.1126/science.1098020 · Cited by 838
Boire, A., Covic, L., Agarwal, A., Jacques, S., Sherifi, S., & Kuliopulos, A. (2005) · Cell · doi:10.1016/j.cell.2004.12.018 · Cited by 838
Pai, R., Soreghan, B., Szabo, I. L., Pavelka, M., Baatar, D., & Tarnawski, A. S. (2002) · Nature Medicine · doi:10.1038/nm0302-289 · Cited by 836
Hida, T., Yatabe, Y., Achiwa, H., Muramatsu, H., Kozaki, K., Nakamura, S., Ogawa, M., Mitsudomi, T., Sugiura, T., & Takahashi, T. (1998) · PubMed · Cited by 818
Overexpression of Cyclooxygenase-2 Is Sufficient to Induce Tumorigenesis in Transgenic Mice
Liu, C. H., Chang, S.-H., Narko, K., Trifan, O. C., Wu, M.-T., Smith, E., Haudenschild, C., Lane, T. F., & Hla, T. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010787200 · Cited by 807
Lasagni, L., Francalanci, M., Annunziato, F., Lazzeri, E., Giannini, S., Cosmi, L., Sagrinati, C., Mazzinghi, B., Orlando, C., Maggi, E., et al. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021897 · Cited by 739
Human cytomegalovirus infection and expression in human malignant glioma.
Cobbs, C., Harkins, L. E., Samanta, M., Gillespie, G. Y., Bharara, S., King, P. H., Nabors, B., Cobbs, C. G., & Britt, W. J. (2002) · PubMed · Cited by 717
Gli and hedgehog in cancer: tumours, embryos and stem cells
Ruiz i Altaba, A., Sánchez, P., & Dahmane, N. (2002) · Nature Reviews Cancer · doi:10.1038/nrc796 · Cited by 708
Arvanitakis, L., Geras-Raaka, E., Varma, A., Gershengorn, M. C., & Cesarman, E. (1997) · Nature · doi:10.1038/385347a0 · Cited by 670
Identification of endothelin–1 in the pathophysiology of metastatic adenocarcinoma of the prostate
Nelson, J. B., Hedican, S. P., George, D. J., Reddi, A. H., Piantadosi, S., Eisenberger, M. A., & Simons, J. W. (1995) · Nature Medicine · doi:10.1038/nm0995-944 · Cited by 622
Carmeci, C., Thompson, D. A., Ring, H. Z., Francke, U., & Weigel, R. J. (1997) · Genomics · doi:10.1006/geno.1997.4972 · Cited by 591
Acceleration of intestinal polyposis through prostaglandin receptor EP2 in ApcΔ716 knockout mice
Sonoshita, M., Takaku, K., Sasaki, N., Sugimoto, Y., Ushikubi, F., Narumiya, S., Oshima, M., & Taketo, M. M. (2001) · Nature Medicine · doi:10.1038/nm0901-1048 · Cited by 587
Connections and Regulation of the Human Estrogen Receptor
McDonnell, D. P., & Norris, J. D. (2002) · Science · doi:10.1126/science.1071884 · Cited by 579
Upregulation of CXCR4 is essential for HER2-mediated tumor metastasis
Li, Y. M., Pan, Y., Wei, Y., Cheng, X., Zhou, B. P., Tan, M., Zhou, X., Xia, W., Hortobagyi, G. N., Yu, D., et al. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.09.027 · Cited by 537
Altered Gs and adenylate cyclase activity in human GH-secreting pituitary adenomas
Vallar, L., Spada, A., & Giannattasio, G. (1987) · Nature · doi:10.1038/330566a0 · Cited by 514
Palmer, J. S., Duffy, D. L., Box, N. F., Aitken, J. F., O'Gorman, L. E., Green, A. C., Hayward, N. K., Martin, N. G., & Sturm, R. A. (2000) · The American Journal of Human Genetics · doi:10.1086/302711 · Cited by 503
Metastasis suppressors alter the signal transduction of cancer cells
Steeg, P. S. (2003) · Nature Reviews Cancer · doi:10.1038/nrc967 · Cited by 502
Genetics of hair and skin color
Rees, J. L. (2003) · Annual Review of Genetics · doi:10.1146/annurev.genet.37.110801.143233 · Cited by 485
Young, D., Waitches, G., Birchmeier, C., Fasano, O., & Wigler, M. (1986) · Cell · doi:10.1016/0092-8674(86)90785-3 · Cited by 481
Visentin, B., Vekich, J. A., Sibbald, B. J., Cavalli, A. L., Moreno, K. M., Matteo, R. G., Garland, W. A., Lu, Y., Yu, S., Hall, H. S., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.02.023 · Cited by 463
Gα12 and Gα13 Stimulate Rho-dependent Stress Fiber Formation and Focal Adhesion Assembly
Buhl, A. M., Johnson, N. L., Dhanasekaran, N., & Johnson, G. L. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.42.24631 · Cited by 448
COX-2: A Molecular Target for Colorectal Cancer Prevention
Brown, J. R., & DuBois, R. N. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.09.051 · Cited by 444
Hino, S.-I., Tanji, C., Nakayama, K. I., & Kikuchi, A. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.20.9063-9072.2005 · Cited by 427
Thrombin receptor overexpression in malignant and physiological invasion processes
Even-Ram, S., Uziely, B., Cohen, P., Grisaru-Granovsky, S., Maoz, M., Ginzburg, Y., Reich, R., Vlodavsky, I., & Bar-Shavit, R. (1998) · Nature Medicine · doi:10.1038/nm0898-909 · Cited by 417
Harris, R. E., Chlebowski, R. T., Jackson, R. D., Frid, D. J., Ascenseo, J. L., Anderson, G. L., Loar, A., Rodabough, R. J., White, E., & McTiernan, A. (2003) · PubMed · Cited by 411
Cancer CXC chemokine networks and tumour angiogenesis
Strieter, R. M., Burdick, M. D., Mestas, J., Gomperts, B., Keane, M. P., & Belperio, J. A. (2006) · European Journal of Cancer · doi:10.1016/j.ejca.2006.01.006 · Cited by 410
Harris, R., Beebe-Donk, J., Doss, H., & Doss, D. (2005) · Oncology Reports · doi:10.3892/or.13.4.559 · Cited by 408
Ectopic Expression of the Serotonin 1c Receptor and the Triggering of Malignant Transformation
Julius, D., Livelli, T. J., Jessell, T. M., & Axel, R. (1989) · Science · doi:10.1126/science.2727693 · Cited by 359
The candidate tumour suppressor protein ING4 regulates brain tumour growth and angiogenesis
Garkavtsev, I., Kozin, S. V., Chernova, O., Xu, L., Winkler, F., Brown, E., Barnett, G. H., & Jain, R. K. (2004) · Nature · doi:10.1038/nature02329 · Cited by 353
SALCEDO, R., & OPPENHEIM, J. J. (2003) · Microcirculation · doi:10.1038/sj.mn.7800200 · Cited by 328
FHL2, a novel tissue-specific coactivator of the androgen receptor
Muller, J. M. (2000) · The EMBO Journal · doi:10.1093/emboj/19.3.359 · Cited by 326
Phillips, R. J., Mestas, J., Gharaee-Kermani, M., Burdick, M. D., Sica, A., Belperio, J. A., Keane, M. P., & Strieter, R. M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500963200 · Cited by 323
Allen, L. F., Lefkowitz, R. J., Caron, M. G., & Cotecchia, S. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.24.11354 · Cited by 322
Genetics of melanoma predisposition
Hayward, N. K. (2003) · Oncogene · doi:10.1038/sj.onc.1206445 · Cited by 321
Depletion of CXCR2 Inhibits Tumor Growth and Angiogenesis in a Murine Model of Lung Cancer
Keane, M. P., Belperio, J. A., Xue, Y. Y., Burdick, M. D., & Strieter, R. M. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.5.2853 · Cited by 305
The genetics of malignant melanoma: lessons from mouse and man
Chin, L. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1145 · Cited by 302
Muscarinic acetylcholine receptor subtypes as agonist-dependent oncogenes.
Gutkind, J. S., Novotny, E. A., Brann, M. R., & Robbins, K. C. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.11.4703 · Cited by 291
Self-citationLiu, G., Duranteau, L., Carel, J.-C., Monroe, J., Doyle, D. A., & Shenker, A. (1999) · New England Journal of Medicine · doi:10.1056/nejm199912023412304 · Cited by 281
Signaling and biological actions of sphingosine 1-phosphate
Hla, T. (2003) · Pharmacological Research · doi:10.1016/s1043-6618(03)00046-x · Cited by 280
Activity-Dependent Internalization of Smoothened Mediated by ß-Arrestin 2 and GRK2
Chen, W., Ren, X.-R., Nelson, C. D., Barak, L. S., Chen, J. K., Beachy, P. A., de Sauvage, F., & Lefkowitz, R. J. (2004) · Science · doi:10.1126/science.1104135 · Cited by 279
Anisowicz, A., Bardwell, L., & Sager, R. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.20.7188 · Cited by 276
Human cytomegalovirus encodes three G protein-coupled receptor homologues
Chee, M. S., Satchwell, S. C., Preddie, E. C., Weston, K., & Barrell, B. G. (1990) · Nature · doi:10.1038/344774a0 · Cited by 276
Kijima, T., Maulik, G., Ma, P. C., Tibaldi, E. V., Turner, R. E., Rollins, B. J., Sattler, M., Johnson, B. E., & Salgia, R. (2002) · PubMed · Cited by 273
Pitson, S. M., Xia, P., Leclercq, T. M., Moretti, P. A. B., Zebol, J. R., Lynn, H. E., Wattenberg, B. W., & Vadas, M. A. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20040559 · Cited by 268
Cell growth control by G protein-coupled receptors: from signal transduction to signal integration
Gutkind, J. S. (1998) · Oncogene · doi:10.1038/sj.onc.1202186 · Cited by 261
Self-citationTumor formation by genetic mutations in the components of the Wnt signaling pathway
Kikuchi, A. (2003) · Cancer Science · doi:10.1111/j.1349-7006.2003.tb01424.x · Cited by 260
Zagzag, D., Krishnamachary, B., Yee, H., Okuyama, H., Chiriboga, L., Ali, M. A., Melamed, J., & Semenza, G. L. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4406 · Cited by 260
Nor, J. E., Christensen, J. B., Liu, J., Peters, M., Mooney, D. J., Strieter, R. M., & Polverini, P. J. (2001) · PubMed · Cited by 257
Estrogen Receptors as Therapeutic Targets in Breast Cancer
Ariazi, E., Ariazi, J., Cordera, F., & Jordan, V. (2006) · Current Topics in Medicinal Chemistry · doi:10.2174/156802606776173483 · Cited by 255
Activation of heterotrimeric G proteins by Smoothened
Riobo, N. A., Saucy, B., DiLizio, C., & Manning, D. R. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0600880103 · Cited by 244
Constitutive Signaling of the Human Cytomegalovirus-encoded Chemokine Receptor US28
Casarosa, P., Bakker, R. A., Verzijl, D., Navis, M., Timmerman, H., Leurs, R., & Smit, M. J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008965200 · Cited by 243
Taguchi, A., Ohmiya, N., Shirai, K., Mabuchi, N., Itoh, A., Hirooka, Y., Niwa, Y., & Goto, H. (2005) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-05-0326 · Cited by 243
Human cytomegalovirus-encoded chemokine receptor US28 promotes tumorigenesis
Maussang, D., Verzijl, D., van Walsum, M., Leurs, R., Holl, J., Pleskoff, O., Michel, D., van Dongen, G. A. M. S., & Smit, M. J. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0604433103 · Cited by 233
Estrogen Receptors as Therapeutic Targets in Breast Cancer
Ariazi, E. A., & Jordan, V. C. (2008) · Methods and Principles in Medicinal Chemistry · doi:10.1002/9783527623297.ch5 · Cited by 230
Protease-Activated Receptors (PAR1 and PAR2) Contribute to Tumor Cell Motility and Metastasis
Shi, X., Gangadharan, B., Brass, L. F., Ruf, W., & Mueller, B. M. (2004) · Molecular Cancer Research · doi:10.1158/1541-7786.395.2.7 · Cited by 230
Ondrey, F. G., Dong, G., Sunwoo, J., Chen, Z., Wolf, J. S., Crowl-Bancroft, C. V., Mukaida, N., & Van Waes, C. (1999) · Molecular Carcinogenesis · doi:10.1002/(sici)1098-2744(199910)26:2<119::aid-mc6>3.0.co;2-n · Cited by 224
Cyclooxygenase‐2: A novel molecular target for the prevention and treatment of head and neck cancer
Lin, D. T., Subbaramaiah, K., Shah, J. P., Dannenberg, A. J., & Boyle, J. O. (2002) · Head & Neck · doi:10.1002/hed.10108 · Cited by 219
Prostaglandin E2 Stimulates the β-Catenin/T Cell Factor-dependent Transcription in Colon Cancer
Shao, J., Jung, C., Liu, C., & Sheng, H. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m413056200 · Cited by 214
Cyclooxygenase-2: a therapeutic target in angiogenesis
Iñiguez, M. A., Rodrı́guez, A., Volpert, O. V., Fresno, M., & Redondo, J. M. (2003) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(02)00011-4 · Cited by 206
Autocrine and paracrine signaling through neuropeptide receptors in human cancer
Heasley, L. E. (2001) · Oncogene · doi:10.1038/sj.onc.1204183 · Cited by 199
Liu, X., Rubin, J. S., & Kimmel, A. R. (2005) · Current Biology · doi:10.1016/j.cub.2005.10.050 · Cited by 198
Sodhi, A., Chaisuparat, R., Hu, J., Ramsdell, A. K., Manning, B. D., Sausville, E. A., Sawai, E. T., Molinolo, A., Gutkind, J. S., & Montaner, S. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.05.026 · Cited by 197
Self-citationXu, L., Stackhouse, B. G., Florence, K. F. D. S., Zhang, W., Shanmugam, N., Ia, S., Zou, Z., Srikantan, V., Augustus, M., Roschke, V., et al. (2000) · PubMed · Cited by 197
G Protein-Coupled Receptor Systems Involved in Cell Growth and Oncogenesis
DHANASEKARAN, N., HEASLEY, L. E., & JOHNSON, G. L. (1995) · Endocrine Reviews · doi:10.1210/edrv-16-3-259 · Cited by 196
Inflammatory chemokines in cancer growth and progression
Rollins, B. J. (2006) · European Journal of Cancer · doi:10.1016/j.ejca.2006.01.002 · Cited by 195
PGE2 Stimulates VEGF Expression in Endothelial Cells via ERK2/JNK1 Signaling Pathways
Pai, R., Szabo, I. L., Soreghan, B. A., Atay, S., Kawanaka, H., & Tarnawski, A. S. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.5494 · Cited by 195
The Wnt connection to tumorigenesis
Behrens, J., & Lustig, B. (2004) · The International Journal of Developmental Biology · doi:10.1387/ijdb.041815jb · Cited by 194
Darmoul, D., Gratio, V., Devaud, H., Lehy, T., & Laburthe, M. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64283-6 · Cited by 193
Schuller, H. M., Tithof, P. K., Williams, M., & Plummer, H. K. (1999) · PubMed · Cited by 189
Wang, B., Hendricks, D. T., Wamunyokoli, F., & Parker, M. I. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2871 · Cited by 183
Radiolabeled peptide conjugates for targeting of the bombesin receptor superfamily subtypes
Smith, C. J., Volkert, W. A., & Hoffman, T. J. (2005) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2005.05.005 · Cited by 181
Viral hijacking of G-protein-coupled-receptor signalling networks
Sodhi, A., Montaner, S., & Gutkind, J. S. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1529 · Cited by 174
Self-citationEstrogen-Related Receptors as Emerging Targets in Cancer and Metabolic Disorders
Ariazi, E., & Jordan, V. (2006) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026610606030203 · Cited by 168
Pǒld, M., Zhu, L. X., Sharma, S. P., Burdick, M. D., Lin, Y., Lee, P. P. N., Põld, A., Luo, J., Krysan, K., Dohadwala, M., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3262 · Cited by 160
Prostaglandin EP receptors: Targets for treatment and prevention of colorectal cancer?
Hull, M. A., Ko, S. C. W., & Hawcroft, G. (2004) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.1031.3.8 · Cited by 158
Lee, W.-P., Tai, D., Lan, K., Li, A. F., Hsu, H.-C., Lin, E.-J. D., Lin, Y.-P., Sheu, M., Li, C., Chang, F.-Y., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0942 · Cited by 155
COX inhibitors and breast cancer
Mazhar, D., Ang, R., & Waxman, J. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6602942 · Cited by 146
Hansen‐Petrik, M., McEntee, M. F., Jull, B. A., Shi, H., Zemel, M. B., & Whelan, J. (2002) · PubMed · Cited by 143
The CXCL12–CXCR4 chemotactic pathway as a target of adjuvant breast cancer therapies
Epstein, R. J. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1473 · Cited by 134
G Proteins in Cancer: The Prostate Cancer Paradigm
Daaka, Y. (2004) · Science s STKE · doi:10.1126/stke.2162004re2 · Cited by 127
Frizzleds: new members of the superfamily of G-protein-coupled receptors
Craig, C. M. (2004) · Frontiers in bioscience · doi:10.2741/1308 · Cited by 119
Prostaglandin E2 Regulates the Nuclear Receptor NR4A2 in Colorectal Cancer
Holla, V. R., Mann, J. R., Shi, Q., & DuBois, R. N. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m507752200 · Cited by 118
Liu, T., Liu, X., Wang, H., Moon, R. T., & Malbon, C. C. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.47.33539 · Cited by 112
Human herpesvirus 6: molecular biology and clinical features
Dockrell, D. H. (2002) · Journal of Medical Microbiology · doi:10.1099/jmm.0.05074-0 · Cited by 112
Metzger, E., Müller, J. M., Ferrari, S., Buettner, R., & Schüle, R. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg023 · Cited by 110
The Prostaglandin E2 Receptor EP2 Is Required for Cyclooxygenase 2–Mediated Mammary Hyperplasia
Chang, S.-H., Ai, Y., BREYER, R. M., Lane, T. F., & Hla, T. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0129 · Cited by 109
Bradykinin receptor subtype 1 expression and function in prostate cancer.
Taub, J. S., Guo, R., Leeb-Lundberg, L. M. F., Madden, J. F., & Daaka, Y. (2003) · PubMed · Cited by 108
Tissue Factor and Fibrin in Tumor Angiogenesis
Fernández, P. M., Patierno, S. R., & Rickles, F. R. (2004) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-2004-822969 · Cited by 107
Booden, M. A., Eckert, L. B., Der, C. J., & Trejo, J. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.5.1990-1999.2004 · Cited by 105
β-Catenin activates the growth factor endothelin-1 in colon cancer cells
Kim, T. H., Xiong, H., Zhang, Z., & Ren, B. (2004) · Oncogene · doi:10.1038/sj.onc.1208237 · Cited by 104
Angiogenesis and G-protein-coupled receptors: signals that bridge the gap
Richard, D. E., Vouret‐Craviari, V., & Pouysségur, J. (2001) · Oncogene · doi:10.1038/sj.onc.1204193 · Cited by 102
Navenot, J.-M., Wang, Z., Chopin, M., Fujii, N., & Peiper, S. C. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1757 · Cited by 91
Lysophosphatidic Acid Is a Major Regulator of Growth-Regulated Oncogene α in Ovarian Cancer
Lee, Z., Swaby, R. F., Liang, Y., Yu, S., Liu, S., Lu, K. H., Bast, R. C., Mills, G. B., & Fang, X. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2947 · Cited by 89
Schruefer, R., Lutze, N., Schymeinsky, J., & Walzog, B. (2004) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00237.2004 · Cited by 88
Androgen Receptor Activation by Gs Signaling in Prostate Cancer Cells
Kasbohm, E. A., Guo, R., Yowell, C. W., Bagchi, G., Kelly, P., Arora, P., Casey, P. J., & Daaka, Y. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m414423200 · Cited by 81
Vischer, H. F., Leurs, R., & Smit, M. J. (2005) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2005.11.006 · Cited by 79
PI3K and RAC signalling in leukocyte and cancer cell migration.
Barber, M. A., & Welch, H. C. E. (2006) · PubMed · Cited by 76
The G12 family of heterotrimeric G proteins and Rho GTPase mediate Sonic hedgehog signalling
Kasai, K., Takahashi, M. P., Osumi, N., Sinnarajah, S., Takeo, T., Ikeda, H., Kehrl, J. H., Itoh, G., & Arnheiter, H. (2004) · Genes to Cells · doi:10.1111/j.1356-9597.2004.00701.x · Cited by 72
Nagy, A., & Schally, A. V. (2005) · Current Pharmaceutical Design · doi:10.2174/1381612053507594 · Cited by 70
Virus-encoded chemokine receptors – putative novel antiviral drug targets
ROSENKILDE, M. M. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.09.017 · Cited by 51
Expression of protease-activated receptor 1 in oral squamous cell carcinoma
Liu, Y., Gilcrease, M. Z., Henderson, Y. C., et al. (2001) · Cancer Letters · doi:10.1016/s0304-3835(01)00504-3 · Cited by 42
Yin, Y., Katz, V., Salah, Z., Maoz, M., Cohen, I., Uziely, B., Turm, H., Grisaru‐Granovsky, S., Suzuki, H., & Bar‐Shavit, R. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4234 · Cited by 41
Leifert, W. R., Aloia, A. L., Bucco, O., Glatz, R., & McMurchie, E. J. (2005) · SLAS DISCOVERY · doi:10.1177/1087057105280517 · Cited by 38
β-Catenin, Cancer, and G Proteins: Not Just for Frizzleds Anymore
Malbon, C. C. (2005) · Science s STKE · doi:10.1126/stke.2922005pe35 · Cited by 35
Tang, C., & Insel, P. A. (2005) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.9.6.1247 · Cited by 32
Association Between Endothelin Receptor B Nonsynonymous Variants and Melanoma Risk
Soufir, N., Meziani, R., Lacapère, J.-J., Bertrand, G., Fumeron, F., Bourillon, A., Gérard, B., Descamps, V., Crickx, B., Ollivaud, L., et al. (2005) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dji253 · Cited by 27
Hoff, A. O., Cote, G. J., Fritsche, H. A., Qiu, H., Schultz, P. N., & Gagel, R. F. (1999) · Neoplasia · doi:10.1038/sj.neo.7900072 · Cited by 22
Re: Association Between Endothelin Receptor B Nonsynonymous Variants and Melanoma Risk
Thirumaran, R. K., Thoelke, A., Ugurel, S., Hemminki, K., Schadendorf, D., & Kumar, R. (2006) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djj336 · Cited by 19
Driessens, M. H. E., Rijthoven, E. A. M. V., Rivière, G. L., & Roos, E. (1996) · Blood · doi:10.1182/blood.v88.8.3116.bloodjournal8883116 · Cited by 10
Cited by
Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex
Konermann, S., Brigham, M. D., Trevino, A. E., Joung, J., Abudayyeh, O. O., Barcena, C., Hsu, P. D., Habib, N., Gootenberg, J. S., Nishimasu, H., et al. (2015) · Nature · doi:10.1038/nature14136 · Cited by 2,825
Regulation of the Hippo-YAP Pathway by G-Protein-Coupled Receptor Signaling
Yu, F.-X., Zhao, B., Panupinthu, N., Jewell, J. L., Lian, I., Wang, L. H., Zhao, J., Yuan, H., Tumaneng, K., Li, H., et al. (2012) · Cell · doi:10.1016/j.cell.2012.06.037 · Cited by 1,628
SCFA: mechanisms and functional importance in the gut
Martin-Gallausiaux, C., Marinelli, L., Blottière, H. M., Larraufie, P., & Lapaque, N. (2021) · Proceedings of the Nutrition Society · doi:10.1017/s0029665120006916 · Cited by 1,480
GAGE: generally applicable gene set enrichment for pathway analysis
Luo, W., Friedman, M. S., Shedden, K., Hankenson, K. D., & Woolf, P. J. (2009) · BMC Bioinformatics · doi:10.1186/1471-2105-10-161 · Cited by 1,333
The Hippo pathway: regulators and regulations.
Yu, F.-X., & Guan, K.-L. (2013) · Genes & Development · doi:10.1101/gad.210773.112 · Cited by 1,231
Metadata
- Authors
- Dorsam, R. T., & Gutkind, J. S.
- Venue
- Nature Reviews Cancer
- Published
- 2007-02
- Volume
- 7
- Issue
- 2
- Pages
- 79-94
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2038809664
- Cited by
- 1,388
- References
- 143
- FWCI
- 3.14
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.